Merck Sues US, Calling Move to Cut Drug Prices ‘Extortion’
Merck & Co. is suing the US over a law that will allow the government to negotiate prescription-drug
2023-06-07 01:48
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20
Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut
When Exondys 51 was approved to treat Duchenne muscular dystrophy, a deadly disease that puts kids in wheelchairs
2023-05-15 07:23